When evaluating Schedule II prescriptions, certain elements must remain unaltered to preserve the integrity and traceability of the order. The patient’s name, the specific drug prescribed, and the prescriber’s signature are non-changeable because altering any of these could misidentify the patient, change or misrepresent the medication ordered, or allow someone to falsely claim authorization from a prescriber. Keeping these three items fixed ensures that the prescription accurately reflects who is receiving the drug, what drug was ordered, and who authorized it. If a correction is needed, it should generally involve obtaining a new prescription or direct authorization from the prescriber, rather than altering an existing one.

DEA Form 225 is the application used for registration to handle controlled substances in activities such as research, manufacturing, or distributing. Researchers who plan to work with controlled substances in a lab must file this form to obtain authorization. Narcotic treatment programs are registered with a different form (not 225), and a domestic chemical business falls under other regulatory pathways, not this form. So, for a new registration among these options, the entity that uses Form 225 is the researcher.

When a pharmacy purchases a drug, the information that must come with the transfer includes three complementary pieces that establish a traceable chain of custody. First is the Transaction Information, which describes the product and the sale details—think drug name, dosage form and strength, packaging, the lot or serial number, the date of the transaction, and the identifying information for both the seller and the purchaser. Second is the Transaction History, which provides the full backstory of the product’s journey through the supply chain, showing every previous transfer from the manufacturer to the current buyer. Third is the Transaction Statement, a certification from the seller that the sale complies with DSCSA requirements and that the information provided is accurate. Together, these three elements ensure traceability, authentication, and accountability for each drug product in the supply chain.

DEA Form 106 is used to report the theft or loss of controlled substances to the Drug Enforcement Administration. It is the official channel for registrants to document what was stolen or lost, when it happened, which substances were involved, and the circumstances surrounding the incident (often including whether police were notified and any investigation details). This helps regulatory authorities monitor potential diversion and take appropriate action. It’s not for initiating prescriptions, reporting medication adverse events, or handling state licensing, which are addressed through separate processes.